Framingham, MA, United States of America

Hitesh Bhagat

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1998-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hitesh Bhagat: Innovator in Sustained Release Solid Dosage Forms

Introduction

Hitesh Bhagat is a notable inventor based in Framingham, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release solid dosage forms. With a total of three patents to his name, Bhagat's work focuses on innovative solutions for health-related challenges.

Latest Patents

Hitesh Bhagat's latest patents include advancements in sustained release solid dosage forms for modulating the colonic microbiome. These patents describe formulations that utilize epigallocatechin gallate (EGCG) or aminosterol compositions. One aspect of his invention involves capsules that contain a plurality of coated solid particulates. Additionally, his work outlines methods for inhibiting, ameliorating, or treating amyloid disorders, specifically targeting conditions such as Parkinson's Disease.

Career Highlights

Throughout his career, Hitesh Bhagat has worked with prominent companies in the pharmaceutical industry. Notable organizations include Axial Therapeutics, Inc. and Oravax-Merieux Co. His experience in these companies has contributed to his expertise in developing innovative drug delivery systems.

Collaborations

Hitesh Bhagat has collaborated with several professionals in his field, including Ryan Barrett and Anthony Stewart Campbell. These collaborations have likely enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Hitesh Bhagat stands out as an inventor dedicated to advancing pharmaceutical technologies. His work on sustained release solid dosage forms has the potential to significantly improve treatment options for various health conditions. His contributions to the field reflect a commitment to innovation and excellence.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…